Impact of intensive infection control team activities on the acquisition of methicillin-resistant Staphylococcus aureus, drug-resistant Pseudomonas aeruginosa and the incidence of Clostridium difficile-associated disease

Journal of Infection and Chemotherapy

Volumn 19, Issue 6, 2013, Pages 1047-1052

  Suzuki, Hiromichi ^a   Senda, Junko ^a   Yamashita, Keita ^a   Tokuda, Yasuharu ^b   Kanesaka, Yohko ^a   Kotaki, Noriko ^a   Ishihara, Hiroko ^a   Ishikawa, Hiroichi ^a  

^a TSUKUBA MEDICAL CENTER HOSPITAL   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Antimicrobial stewardship program; Electronic medical record; Infection control; Multidrug resistant organism

Indexed keywords

AMIKACIN; CARBAPENEM; QUINOLONE DERIVATIVE; VANCOMYCIN;

AMPICILLIN RESISTANT ENTEROCOCCUS INFECTION; APRON; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; DRUG USE; ENTEROCOCCAL INFECTION; GLOVE; HOSPITAL PATIENT; HUMAN; INCIDENCE; INFECTION CONTROL; INFECTION CONTROL TEAM; MAJOR CLINICAL STUDY; MEDICAL RECORD; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MULTIDRUG RESISTANT PSEUDOMONAS AERUGINOSA; PARAMEDICAL PERSONNEL; PHYSICIAN; PROTECTIVE EQUIPMENT; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; SANITATION; TEACHING HOSPITAL;

ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; HUMANS; INFECTION CONTROL; JAPAN; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; STAPHYLOCOCCAL INFECTIONS;

EID: 84890858631     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1007/s10156-013-0621-x     Document Type: Article

References (32)

1. Joo EJ, Kang CI, Ha YE, Kang SJ, Park SY, Chung DR, et al. Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia: clinical impact of antimicrobial resistance on outcome. Microb Drug Resist. 2011;17:305-12.
2. Welfare MR, Lalayiannis LC, Martin KE, Corbett S, Marshall B, Sarma JB. Co-morbidities as predictors of mortality in Clostridium difficile infection and derivation of the ARC predictive score. J Hosp Infect. 2011;79:359-63.
3. Isobe M, Uejima E, Seki M, Yamagishi Y, Miyawaki K, Yabuno K, et al. Methicillin-resistant Staphylococcus aureus bacteremia at a university hospital in Japan. J Infect Chemother. 2012;18:841-7.
4. Takata T, Miyazaki M, Li H, Healy M, Frye S, Tanaka K, et al. Methicillin-resistant Staphylococcus aureus bloodstream infections in a Japanese university hospital between 1987 and 2004. J Infect Chemother. 2012;18:199-206.
5. Wenisch JM, Schmid D, Tucek G, Kuo HW, Allerberger F, Michl V, et al. A prospective cohort study on hospital mortality due to Clostridium difficile infection. Infection. 2012;40:479-84.
6. Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010;31:431-55.
7. Calfee DP, Salgado CD, Classen D, Arias KM, Podgorny K, Anderson DJ, et al. Strategies to prevent transmission of methicillin-resistant Staphylococcus aureus in acute care hospitals. Infect Control Hosp Epidemiol. 2008;29:62-80.
8. Siegel JD, Rhinehart E, Jackson M, Chiarello L. Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control. 2007;35:165-93.
9. Japanese Society of Environmental Infections. Position paper for the infection control of multidrug-resistant gram-negative bacteria, first edition. Jpn J Environ Infect. 2011;26:1-22.
10. Kac G, Grohs P, Durieux P, Trinquart L, Gueneret M, Rodi A, et al. Impact of electronic alerts on isolation precautions for patients with multidrug-resistant bacteria. Arch Intern Med. 2007;167:2086-90.
11. Muder RR, Cunningham C, McCray E, Squier C, Perreiah P, Jain R, et al. Implementation of an industrial systems-engineering approach to reduce the incidence of methicillin-resistant Staphylococcus aureus infection. Infect Control Hosp Epidemiol. 2008;29702-8.
12. Edwards R, Charani E, Sevdalis N, Alexandrou B, Sibley E, Mullett D, et al. Optimisation of infection prevention and control in acute health care by use of behaviour change: a systematic review. Lancet Infect Dis. 2012;12:318-29.
13. Fishman N, Patterson J, Saiman L, Srinivasan A, Trivedi K, van Schooneveld T, et al. Policy statement on antimicrobial stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS). Infect Control Hosp Epidemiol. 2012;33:322-7.
14. Huang SS, Yokoe DS, Hinrichsen VL, Spurchise LS, Datta R, Miroshnik I, et al. Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis. 2006;43:971-8.
15. Johnson AP, Davies J, Guy R, Abernethy J, Sheridan E, Pearson A, et al. Mandatory surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in England: the first 10 years. J Antimicrob Chemother. 2012;67:802-9.
16. Hayden MK, Bonten MJ, Blom DW, Lyle EA, van de Vijver DA, Weinstein RA. Reduction in acquisition of vancomycin-resistant enterococcus after enforcement of routine environmental cleaning measures. Clin Infect Dis. 2006;42:1552-60.
17. Hacek DM, Ogle AM, Fisher A, Robicsek A, Peterson LR. Significant impact of terminal room cleaning with bleach on reducing nosocomial Clostridium difficile. Am J Infect Control. 2010;38:350-3.
18. Stone SP, Fuller C, Savage J, Cookson B, Hayward A, Cooper B, et al. Evaluation of the national Cleanyourhands campaign to reduce Staphylococcus aureus bacteraemia and Clostridium difficile infection in hospitals in England and Wales by improved hand hygiene: four year, prospective, ecological, interrupted time series study. BMJ. 2012;344:e3005.
19. Tschudin-Sutter S, Frei R, Dangel M, Stranden A, Widmer AF. Rate of transmission of extended-spectrum Beta-lactamase-producing enterobacteriaceae without contact isolation. Clin Infect Dis. 2012;55:1505-11.
20. Institute of Japan Nosocomial Infections Surveillance. Japan Nosocomial Infections Surveillance (JANIS): decision criteria for drug-resistant organisms. Tokyo: Ministry of Health, Labour and Welfare; 2010. Available from: http://www.nih-janis.jp/section/kensa.html.
21. World Health Organization Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment, 2012. Oslo: WHO; 2011. Available from: http://www.whocc.no/atc-ddd-index/.
22. Safdar N, Maki DG. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med. 2002;136:834-44.
23. Martinez-Capolino C, Reyes K, Johnson L, Sullivan J, Samuel L, Digiovine B, et al. Impact of active surveillance on methicillin-resistant Staphylococcus aureus transmission and hospital resource utilisation. J Hosp Infect. 2010;74:232-7.
24. Rodriguez-Bano J, Garcia L, Ramirez E, Lupion C, Muniain MA, Velasco C, et al. Long-term control of endemic hospital-wide methicillin-resistant Staphylococcus aureus (MRSA): the impact of targeted active surveillance for MRSA in patients and healthcare workers. Infect Control Hosp Epidemiol. 2010;31:786-95.
25. Kang J, Mandsager P, Biddle AK, Weber DJ. Cost-effectiveness analysis of active surveillance screening for methicillin-resistant Staphylococcus aureus in an academic hospital setting. Infect Control Hosp Epidemiol. 2012;33:477-86.
26. Sanford MD, Widmer AF, Bale MJ, Jones RN, Wenzel RP. Efficient detection and long-term persistence of the carriage of methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 1994;19:1123-8.
27. Nakamura A, Miyake K, Misawa S, Kuno Y, Horii T, Kondo S, et al. Meropenem as predictive risk factor for isolation of multidrug-resistant Pseudomonas aeruginosa. J Hosp Infect. 2013;83:153-5.
28. Soeda H, Kaneko A, Inubuse A, Akashi T, Chiba K, Satoh K, et al. Effect of broad spectrum antimicrobial agents use monitoring policy on drug resistance in Pseudomonas aeruginosa. Jpn J Environ Infect. 2010;25:158-62.
29. Falagas ME, Kopterides P. Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature. J Hosp Infect. 2006;64:7-15.
30. Gilbert K, Stafford C, Crosby K, Fleming E, Gaynes R. Does hand hygiene compliance among health care workers change when patients are in contact precaution rooms in ICUs? Am J Infect Control. 2010;38:515-7.
31. Cohen B, Clock SA, Larson E, Behta M, Ross B, Saddul R, et al. Documentation of contact precautions in an electronic health record. J Nurs Care Qual. 2011;26:252-9.
32. Morikane K. Infection control in healthcare settings in Japan. J Epidemiol. 2012 5;22:86-90.